Differences in Oncogenic Potency but Not Target Cell Specificity Distinguish the Two Forms of the BCR/ABL Oncogene.

Molecular and Cellular Biology - United States
doi 10.1128/mcb.11.9.4710
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

The Human Leukemia Oncogene BCR-Abl Abrogates the Anchorage Requirement but Not the Growth Factor Requirement for Proliferation.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1995English

Kinase Domain Mutants of BCR Enhance BCR-Abl Oncogenic Effects

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

MT1-MMP as a Downstream Target of BCR-ABL/ABL Interactor 1 Signaling: Polarized Distribution and Involvement in BCR-ABL-stimulated Leukemic Cell Migration

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

C3G Is Tyrosine-Phosphorylated After Integrin-Mediated Cell Adhesion in Normal but Not in BCR/Abl Expressing Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
1998English

Development of a Potent Protein Degrader Against Oncogenic BCR-ABL Protein

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2019English

Bcr: A Negative Regulator of the BCR-Abl Oncoprotein in Leukemia

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Signaling Pathways Activated by Oncogenic Forms of Abl Tyrosine Kinase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

Protein Kinase CKIIa Interacts With the BCR Moiety of BCR/Abl and Mediates Proliferation of BCR/Abl-Expressing Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

BCR-ABL Tyrosine Kinase

Science-Business eXchange
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy